Interactive Communication Technologies and Nicotine Replacement Therapy Sampling for Smokers
Intervention Combining Interactive Communication Technologies and Nicotine Replacement Therapy Sampling for Proactively Recruited Smokers in Smoking Hotspots: a Pragmatic Randomized Controlled Trial
1 other identifier
interventional
664
1 country
1
Brief Summary
Brief advice combined with active referral to smoking cessation (SC) services increases quitting. We aim to strengthen the effect of combined intervention by using interactive communication technologies and nicotine replacement therapy sampling (NRT-S).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2019
CompletedFirst Posted
Study publicly available on registry
June 28, 2019
CompletedStudy Start
First participant enrolled
August 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedMay 23, 2022
May 1, 2022
1.7 years
June 12, 2019
May 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Biochemically validated abstinence of NRT-S +IM Apps and Chatbot vs. regular SMS
NRT-S +IM Apps and Chatbot vs. regular SMS on validated abstinence defined as exhaled carbon monoxide \<4ppm
At 6-month follow-up
Biochemically validated abstinence of NRT-S +IM Apps and Chatbot vs. regular SMS
NRT-S +IM Apps and Chatbot vs. regular SMS on validated abstinence defined as exhaled carbon monoxide \<4ppm
At 12-month follow-up
Secondary Outcomes (17)
Self-reported 7-day point prevalence abstinence
At 6-month follow-up
Self-reported 7-day point prevalence abstinence
At 12-month follow-up
Self-reported past 24-week continuous abstinence
At 6-month follow-up
Self-reported past 24-week continuous abstinence
At 12-month follow-up
Planned quit day
At 6-month follow-up
- +12 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALBrief advice (AWARD model) + NRT-S + IM Apps and Chatbot
Control group
ACTIVE COMPARATORBrief advice (AWARD model) + regular SMS
Interventions
Ask: smoking habit, quit intention and attempt, smoking reduction intention, previous quitting experience including NRT and SC use. Warn: smokers will be orally warned about the harms of smoking and receive a A5-sized leaflet, which includes some shocking pictures of smoking-related diseases, and SC services information. Advise: smokers will be advised to quit as soon as possible and use NRT or SC services. Refer: smokers will be encouraged to seek SC services for free NRT or other SC services. Those who agreed will be actively referred to their preferred SC services. The collected contact information with consent will be sent to the SC services providers for a quick appointment and follow-up. Do-it-again: Relapsed smokers (identified during follow-ups and IM conversation) will receive the "Advise" and "Refer" intervention.
One-week free NRT (gum or patch) will be provided with dosage based on time to first cigarette smoking after waking up in the morning and previous NRT use (standard practice and according to specific NRT product instructions). Subjects who have first cigarette \<30 minutes in the morning or have previously used NRT, will receive 4mg nicotine gum or 21mg nicotine patch. Those who have first cigarette \>30 minutes after waking up and have not previously used NRT will receive 2mg nicotine gum or 14mg nicotine patch. NRT use and potential side effects will be briefly explained orally based on standardized script according to the product instructions. An NRT use card containing reminders of NRT use and potential side effects will be given.
Twelve-week personalized behavioral support will be delivered using interactive communication technologies using (1) regular tailored messages on abstinence, and (2) synchronous IM Apps conversation with trained SC advisors, and (3) a Chatbot: A Chatbot will be built using open source NLP and machine intelligence platforms. The unstructured text data from our previous study (ClinicalTrials.gov ID: NCT03182790) will be used to train the proposed Chatbot. We will draft responses for each identified question. The final version will be incorporated with Application Programming Interface (API) integration into user-friendly apps (iOS/Android/web app) with a backend server support and continuous data collection for potential bigdata analysis.
Regular SMS messages focus on general health and remind the importance of participating in the follow-up surveys and biochemical validation for quitting
Eligibility Criteria
You may qualify if:
- Adult smokers aged 18+ years who smoke cigarette(s) daily.
- Exhaled carbon monoxide (CO) level of ≥ 4ppm.
- Having smartphones and willing to install IM Apps and a Chatbot.
- Hong Kong residents able to read and communicate in Chinese (Cantonese or Putonghua).
You may not qualify if:
- Smokers who have psychiatric/psychological diseases/on regular psychotropic medications.
- Smokers who are using SC medication, NRT, other SC services or projects.
- Smokers who have contraindication for NRT use: severe angina, arrhythmia, myocardia infraction, pregnancy (or intended to become pregnant \<6 months) or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Food and Health Bureau, Hong Kongcollaborator
Study Sites (1)
School of Nursing, The University of Hong Kong
Hong Kong, Hong Kong
Related Publications (1)
Guo N, Luk TT, Wu YS, Guo Z, Chu JCL, Cheung YTD, Chan CHH, Kwok TTO, Wong VYL, Wong CKH, Lee JJ, Kwok YK, Viswanath K, Lam TH, Wang MP. Effect of mobile interventions with nicotine replacement therapy sampling on long-term smoking cessation in community smokers: A pragmatic randomized clinical trial. Tob Induc Dis. 2023 Mar 24;21:44. doi: 10.18332/tid/160168. eCollection 2023.
PMID: 36969982DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Man Ping Wang, PhD
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 12, 2019
First Posted
June 28, 2019
Study Start
August 19, 2019
Primary Completion
May 8, 2021
Study Completion
September 30, 2021
Last Updated
May 23, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share